Ghana Must Fund Its Own HIV Fight as Foreign Aid Dries Up, Commission Warns

The Ghana AIDS Commission has sounded a clear alarm: the country can no longer afford to rely on foreign donors to bankroll its HIV response. With external funding shrinking, the Commission is calling on the government to step up and take direct financial responsibility for HIV prevention, testing, and treatment services across the country.

The funding crisis explained

For decades, Ghana's HIV and AIDS programmes have been substantially supported by international partners, including global health funds and bilateral donors. These external sources have historically covered a significant portion of the costs of antiretroviral drugs, testing kits, public awareness campaigns, and the training of health workers. However, the global funding landscape has shifted considerably in recent years, with donor countries and international health financing bodies redirecting resources or reducing their overall health aid budgets.

The Ghana AIDS Commission, which coordinates the national response to HIV and AIDS, has flagged this trend as a serious threat to the gains Ghana has made in managing the epidemic. Without a reliable alternative source of funding, there is a real risk that essential services could be disrupted — leaving people living with HIV without consistent access to treatment, and weakening prevention efforts that keep new infections in check.

Why it matters for Ghana

Ghana has made measurable progress in its HIV response over the years, gradually reducing transmission rates and improving the quality of life for those living with the virus. That progress, however, is fragile. HIV treatment is not a one-off intervention — it requires sustained, long-term financing to keep patients on medication and to maintain the health infrastructure that supports testing and counselling.

A drop in funding does not simply mean fewer resources; it can directly translate into stock-outs of antiretroviral drugs, reduced testing coverage, and a slowdown in the education programmes that prevent new infections. Vulnerable populations — including young women, sex workers, and people in rural communities — are typically the first to feel the impact when services are scaled back.

Beyond the human cost, there is also an economic argument for stronger domestic investment. Untreated HIV leads to higher rates of illness and death among working-age adults, placing a greater burden on Ghana's health system and reducing productivity. Investing in prevention and treatment now is widely recognised by health economists as far cheaper than managing the long-term consequences of an unchecked epidemic.

What needs to happen next

The Commission's call is essentially a push for a fundamental shift in how Ghana thinks about health financing. Rather than treating domestic HIV funding as a supplement to foreign aid, the government is being asked to treat it as a core budget priority. This could involve increasing the allocation to the Ghana AIDS Commission within the national health budget, strengthening the role of the National Health Insurance Scheme in covering HIV-related services, and exploring innovative domestic financing mechanisms.

Civil society organisations and health advocates have long argued that greater ownership of the HIV response — both financially and in terms of policy — will make Ghana's programmes more sustainable and better tailored to local realities. The Commission's latest intervention adds institutional weight to that argument.

• Ghana's HIV programmes have long depended heavily on international donor financing.
• The Commission warns that declining external support threatens treatment and prevention services.
• Greater domestic budget allocation is now seen as essential to sustaining the national HIV response.